Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

SRPT – sarepta therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SRPT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
08:09 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Estepan Ian Michael
Report
3/13
08:07 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Wong Ryan Ho-Yan
Low Report
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Wong Ryan Ho-Yan
Report
3/13
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Rodino-Klapac Louise
Report
3/13
08:03 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 12 Filed by: Mayo Stephen
Low Report
Form 4 Sarepta Therapeutics, For: Mar 12 Filed by: Mayo Stephen
Report
3/13
08:01 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Rothfuss Cristin
Low Report
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Rothfuss Cristin
Report
3/12
04:27 pm
srpt
Form 144 Sarepta Therapeutics, Filed by: Mayo Stephen
Medium Report
Form 144 Sarepta Therapeutics, Filed by: Mayo Stephen
Report
3/11
08:08 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Wong Ryan Ho-Yan
Low Report
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Wong Ryan Ho-Yan
Report
3/11
08:07 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Rothfuss Cristin
Low Report
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Rothfuss Cristin
Report
3/11
08:04 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Rodino-Klapac Louise
Report
3/11
08:01 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Mar 09 Filed by: Estepan Ian Michael
Report
3/3
08:07 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Rothfuss Cristin
Low Report
Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Rothfuss Cristin
Report
3/3
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Wong Ryan Ho-Yan
Low Report
Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Wong Ryan Ho-Yan
Report
3/3
08:04 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Estepan Ian Michael
Report
3/3
08:02 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Rodino-Klapac Louise
Report
3/2
08:00 am
srpt
Form 4 Sarepta Therapeutics, For: Feb 26 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Feb 26 Filed by: Estepan Ian Michael
Report
3/2
07:03 am
srpt
Form 10-K Sarepta Therapeutics, For: Dec 31
Low Report
Form 10-K Sarepta Therapeutics, For: Dec 31
Report
2/27
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Feb 25 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Feb 25 Filed by: Estepan Ian Michael
Report
2/27
08:03 pm
srpt
Form 4 Sarepta Therapeutics, For: Feb 25 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Feb 25 Filed by: Rodino-Klapac Louise
Report
2/25
05:10 pm
srpt
Form 8-K Sarepta Therapeutics, For: Feb 25
Low Report
Form 8-K Sarepta Therapeutics, For: Feb 25
Report
2/25
04:11 pm
srpt
Form 8-K Sarepta Therapeutics, For: Feb 25
Medium Report
Form 8-K Sarepta Therapeutics, For: Feb 25
Report
2/13
11:53 am
srpt
Form SCHEDULE 13G Sarepta Therapeutics, Filed by: AQR CAPITAL MANAGEMENT LLC
Low Report
Form SCHEDULE 13G Sarepta Therapeutics, Filed by: AQR CAPITAL MANAGEMENT LLC
Report
2/13
06:04 am
srpt
Form 13F-HR Sarepta Therapeutics, For: Dec 31
Low Report
Form 13F-HR Sarepta Therapeutics, For: Dec 31
Report
1/29
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Jan 29 Filed by: Nicaise Claude
Medium Report
Form 4 Sarepta Therapeutics, For: Jan 29 Filed by: Nicaise Claude
Report
1/29
08:04 pm
srpt
Form 4 Sarepta Therapeutics, For: Jan 27 Filed by: BEHRENS M KATHLEEN
Medium Report
Form 4 Sarepta Therapeutics, For: Jan 27 Filed by: BEHRENS M KATHLEEN
Report
1/21
12:34 pm
srpt
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: BlackRock, Inc.
Low Report
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: BlackRock, Inc.
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0